APO Research
Talk to an analyst

APO RESEARCH · REPORT

Foot and Mouth Disease (FMD) Vaccines

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Selected research

Industry Research

Foot and Mouth Disease (FMD) Vaccines Industry Research Report 2026

21 December 2025145 pages

Choose your research edition.

Industry ResearchFoot and Mouth Disease (FMD) Vaccines Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

Read the full market overview

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

Report Scope

This report quantifies the global Foot and Mouth Disease (FMD) Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Foot and Mouth Disease (FMD) Vaccines Market by Company

Jinyu Group

Cavet Bio

Indian Immunologicals

Tecon Group

CAHIC

Shen Lian

Biogenesis Bagó

BIGVET Biotech

Boehringer Ingelheim

MSD Animal Health

CEVA

FGBI

Bayer HealthCare

Brilliant Bio Pharma

VECOL

Sanofi (Merial)

VETAL

BVI

LIMOR

ME VAC

Agrovet

Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Foot and Mouth Disease (FMD) Vaccines Segment by Application

Cattle

Pig

Sheep and Goat

Others

Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Foot and Mouth Disease (FMD) Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Foot and Mouth Disease (FMD) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Foot and Mouth Disease (FMD) Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) of Manufacturers (2021-2026) Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Foot and Mouth Disease (FMD) Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Foot and Mouth Disease (FMD) Vaccines Average Price (USD/K Doses) of Manufacturers (2021-2026) Table 11. Global Foot and Mouth Disease (FMD) Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Type & Application Table 14. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Foot and Mouth Disease (FMD) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Jinyu Group Company Information Table 19. Jinyu Group Business Overview Table 20. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 21. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 22. Jinyu Group Recent Developments Table 23. Cavet Bio Company Information Table 24. Cavet Bio Business Overview Table 25. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 26. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 27. Cavet Bio Recent Developments Table 28. Indian Immunologicals Company Information Table 29. Indian Immunologicals Business Overview Table 30. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 31. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 32. Indian Immunologicals Recent Developments Table 33. Tecon Group Company Information Table 34. Tecon Group Business Overview Table 35. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 36. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 37. Tecon Group Recent Developments Table 38. CAHIC Company Information Table 39. CAHIC Business Overview Table 40. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 41. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 42. CAHIC Recent Developments Table 43. Shen Lian Company Information Table 44. Shen Lian Business Overview Table 45. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 46. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 47. Shen Lian Recent Developments Table 48. Biogenesis Bagó Company Information Table 49. Biogenesis Bagó Business Overview Table 50. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 51. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 52. Biogenesis Bagó Recent Developments Table 53. BIGVET Biotech Company Information Table 54. BIGVET Biotech Business Overview Table 55. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 56. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 57. BIGVET Biotech Recent Developments Table 58. Boehringer Ingelheim Company Information Table 59. Boehringer Ingelheim Business Overview Table 60. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 61. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 62. Boehringer Ingelheim Recent Developments Table 63. MSD Animal Health Company Information Table 64. MSD Animal Health Business Overview Table 65. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 66. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 67. MSD Animal Health Recent Developments Table 68. CEVA Company Information Table 69. CEVA Business Overview Table 70. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 71. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 72. CEVA Recent Developments Table 73. FGBI Company Information Table 74. FGBI Business Overview Table 75. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 76. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 77. FGBI Recent Developments Table 78. Bayer HealthCare Company Information Table 79. Bayer HealthCare Business Overview Table 80. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 81. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 82. Bayer HealthCare Recent Developments Table 83. Brilliant Bio Pharma Company Information Table 84. Brilliant Bio Pharma Business Overview Table 85. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 86. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 87. Brilliant Bio Pharma Recent Developments Table 88. VECOL Company Information Table 89. VECOL Business Overview Table 90. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 91. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 92. VECOL Recent Developments Table 93. Sanofi (Merial) Company Information Table 94. Sanofi (Merial) Business Overview Table 95. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 96. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 97. Sanofi (Merial) Recent Developments Table 98. VETAL Company Information Table 99. VETAL Business Overview Table 100. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 101. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 102. VETAL Recent Developments Table 103. BVI Company Information Table 104. BVI Business Overview Table 105. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 106. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 107. BVI Recent Developments Table 108. LIMOR Company Information Table 109. LIMOR Business Overview Table 110. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 111. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 112. LIMOR Recent Developments Table 113. ME VAC Company Information Table 114. ME VAC Business Overview Table 115. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 116. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 117. ME VAC Recent Developments Table 118. Agrovet Company Information Table 119. Agrovet Business Overview Table 120. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 121. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 122. Agrovet Recent Developments Table 123. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (M Doses) Table 125. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2026) Table 126. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (M Doses) Table 127. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2027-2032) Table 128. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2026) Table 130. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2027-2032) Table 132. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 134. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 135. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 139. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 140. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 144. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 145. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 149. South America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 150. South America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 154. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 155. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 158. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 159. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2026) Table 160. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2027-2032) Table 161. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2026) Table 164. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2027-2032) Table 165. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 166. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 167. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 168. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 169. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2026) Table 170. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2027-2032) Table 171. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2026) Table 174. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2027-2032) Table 175. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 176. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 180. Foot and Mouth Disease (FMD) Vaccines Customers List Table 181. Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 182. Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 183. Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Foot and Mouth Disease (FMD) Vaccines Product Image Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (M Doses) Figure 8. Global Foot and Mouth Disease (FMD) Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 9. Emergency Vaccines Product Image Figure 10. Conventional Vaccines Product Image Figure 11. Cattle Product Image Figure 12. Pig Product Image Figure 13. Sheep and Goat Product Image Figure 14. Others Product Image Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region in 2025 Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region in 2025 Figure 22. North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country in 2025 Figure 23. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 24. North America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021-2032) Figure 25. United States Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country in 2025 Figure 29. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 30. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021-2032) Figure 31. Germany Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country in 2025 Figure 42. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021-2032) Figure 44. China Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country in 2025 Figure 53. South America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 54. South America Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021-2032) Figure 55. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country in 2025 Figure 60. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2021-2032) Figure 62. Egypt Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032) Figure 68. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032) Figure 69. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/K Doses) by Type (2021-2032) Figure 70. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032) Figure 71. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032) Figure 72. Global Foot and Mouth Disease (FMD) Vaccines Price (USD/K Doses) by Application (2021-2032) Figure 73. Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 74. Foot and Mouth Disease (FMD) Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Cattle
  • Pig
  • Sheep and Goat
  • Others
Companies covered
  • Jinyu Group
  • Cavet Bio
  • Indian Immunologicals
  • Tecon Group
  • CAHIC
  • Shen Lian
  • Biogenesis Bagó
  • BIGVET Biotech
  • Boehringer Ingelheim
  • MSD Animal Health
  • CEVA
  • FGBI
  • Bayer HealthCare
  • Brilliant Bio Pharma
  • VECOL
  • Sanofi (Merial)
  • VETAL
  • BVI
  • LIMOR
  • ME VAC
  • Agrovet

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032)
  5. 2.2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (2021-2032)
  6. 2.3 Foot and Mouth Disease (FMD) Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Emergency Vaccines
  9. 2.3.3 Conventional Vaccines
  10. 2.4 Foot and Mouth Disease (FMD) Vaccines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Cattle
  13. 2.4.3 Pig
  14. 2.4.4 Sheep and Goat
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses) of Manufacturers (2021-2026)
  3. 3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Foot and Mouth Disease (FMD) Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Foot and Mouth Disease (FMD) Vaccines, Established Date
  9. 3.9 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Jinyu Group
  2. 4.1.1 Jinyu Group Company Information
  3. 4.1.2 Jinyu Group Business Overview
  4. 4.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 4.1.5 Jinyu Group Recent Developments
  7. 4.2 Cavet Bio
  8. 4.2.1 Cavet Bio Company Information
  9. 4.2.2 Cavet Bio Business Overview
  10. 4.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 4.2.5 Cavet Bio Recent Developments
  13. 4.3 Indian Immunologicals
  14. 4.3.1 Indian Immunologicals Company Information
  15. 4.3.2 Indian Immunologicals Business Overview
  16. 4.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 4.3.5 Indian Immunologicals Recent Developments
  19. 4.4 Tecon Group
  20. 4.4.1 Tecon Group Company Information
  21. 4.4.2 Tecon Group Business Overview
  22. 4.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 4.4.5 Tecon Group Recent Developments
  25. 4.5 CAHIC
  26. 4.5.1 CAHIC Company Information
  27. 4.5.2 CAHIC Business Overview
  28. 4.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 4.5.5 CAHIC Recent Developments
  31. 4.6 Shen Lian
  32. 4.6.1 Shen Lian Company Information
  33. 4.6.2 Shen Lian Business Overview
  34. 4.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 4.6.5 Shen Lian Recent Developments
  37. 4.7 Biogenesis Bagó
  38. 4.7.1 Biogenesis Bagó Company Information
  39. 4.7.2 Biogenesis Bagó Business Overview
  40. 4.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 4.7.5 Biogenesis Bagó Recent Developments
  43. 4.8 BIGVET Biotech
  44. 4.8.1 BIGVET Biotech Company Information
  45. 4.8.2 BIGVET Biotech Business Overview
  46. 4.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 4.8.5 BIGVET Biotech Recent Developments
  49. 4.9 Boehringer Ingelheim
  50. 4.9.1 Boehringer Ingelheim Company Information
  51. 4.9.2 Boehringer Ingelheim Business Overview
  52. 4.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 4.9.5 Boehringer Ingelheim Recent Developments
  55. 4.10 MSD Animal Health
  56. 4.10.1 MSD Animal Health Company Information
  57. 4.10.2 MSD Animal Health Business Overview
  58. 4.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 4.10.5 MSD Animal Health Recent Developments
  61. 4.11 CEVA
  62. 4.11.1 CEVA Company Information
  63. 4.11.2 CEVA Business Overview
  64. 4.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 4.11.5 CEVA Recent Developments
  67. 4.12 FGBI
  68. 4.12.1 FGBI Company Information
  69. 4.12.2 FGBI Business Overview
  70. 4.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 4.12.5 FGBI Recent Developments
  73. 4.13 Bayer HealthCare
  74. 4.13.1 Bayer HealthCare Company Information
  75. 4.13.2 Bayer HealthCare Business Overview
  76. 4.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 4.13.5 Bayer HealthCare Recent Developments
  79. 4.14 Brilliant Bio Pharma
  80. 4.14.1 Brilliant Bio Pharma Company Information
  81. 4.14.2 Brilliant Bio Pharma Business Overview
  82. 4.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 4.14.5 Brilliant Bio Pharma Recent Developments
  85. 4.15 VECOL
  86. 4.15.1 VECOL Company Information
  87. 4.15.2 VECOL Business Overview
  88. 4.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 4.15.5 VECOL Recent Developments
  91. 4.16 Sanofi (Merial)
  92. 4.16.1 Sanofi (Merial) Company Information
  93. 4.16.2 Sanofi (Merial) Business Overview
  94. 4.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 4.16.5 Sanofi (Merial) Recent Developments
  97. 4.17 VETAL
  98. 4.17.1 VETAL Company Information
  99. 4.17.2 VETAL Business Overview
  100. 4.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 4.17.5 VETAL Recent Developments
  103. 4.18 BVI
  104. 4.18.1 BVI Company Information
  105. 4.18.2 BVI Business Overview
  106. 4.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 4.18.5 BVI Recent Developments
  109. 4.19 LIMOR
  110. 4.19.1 LIMOR Company Information
  111. 4.19.2 LIMOR Business Overview
  112. 4.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 4.19.5 LIMOR Recent Developments
  115. 4.20 ME VAC
  116. 4.20.1 ME VAC Company Information
  117. 4.20.2 ME VAC Business Overview
  118. 4.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 4.20.5 ME VAC Recent Developments
  121. 4.21 Agrovet
  122. 4.21.1 Agrovet Company Information
  123. 4.21.2 Agrovet Business Overview
  124. 4.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 4.21.5 Agrovet Recent Developments
5 Global Foot and Mouth Disease (FMD) Vaccines Market Scenario by Region
  1. 5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032) & (M Doses)
  3. 6.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032) & (M Doses)
  3. 7.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 8.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
  5. 8.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
  8. 8.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
9 Global Foot and Mouth Disease (FMD) Vaccines Analyzing Market Dynamics
  1. 9.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 9.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 9.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 9.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst